Rosmarinic acid, a polyphenol, ameliorates hyperglycemia by regulating the key enzymes of carbohydrate metabolism in high fat diet - STZ induced experimental diabetes mellitus

Biomedicine and Preventive Nutrition

Volumn 4, Issue 3, 2014, Pages 431-437

  Jayanthy, G ^a   Subramanian, S ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Carbohydrate metabolizing enzymes; Glucose; Insulin; Rosmarinic acid; Type 2 diabetes

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; FRUCTOSE BISPHOSPHATASE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE; HEXOKINASE; METFORMIN; PYRUVATE KINASE; ROSMARINIC ACID; STREPTOZOCIN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME REGULATION; EXPERIMENTAL DIABETES MELLITUS; FLUID INTAKE; GLYCEMIC CONTROL; GLYCOSYLATION; LIPID DIET; MALE; MORBIDITY; MORTALITY; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

ANIMALIA; OCIMUM; ORIGANUM; POLIOMINTHA; RATTUS; THYMUS VULGARIS;

EID: 84905967982     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2014.03.006     Document Type: Article

References (58)

1. Whiting D.R., Guariguanta L., Weil C., Shaw J.E. Diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
2. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
3. Henriksen E.J., Teachey M.K., Lindborg K.A., Diehl C.J., Beneze A.N. The high fat-fed lean Zucker rat: a spontaneous isocaloric model of fat-induced insulin resistance associated with muscleGSK-3 overactivity. Am J Physiol Regul Integr Comp Physiol 2008, 294:1813-1821.
4. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001, 50:537-546.
5. Reed M.J., Meszaros K., Entes L.J. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 2000, 49(11):1390-1394.
6. Sahin K., Onderci M., Tuzcu M. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. Metabolism 2007, 56:1233-1240.
7. Srinivasan K., Viswanad B., Asrat L., Kaul C.L., Ramarao P. Combination of high fat diet fed and low dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005, 52:313-320.
8. Li P.B., Lin W.L., Wang Y.G., Peng W., Cai X.Y., Su W.W. Antidiabetic activities of oligosaccharides of Ophiopogonis japonicus in experimental type 2 diabetic rats. IntJ Bio Macromol 2012, 51:749-755.
9. Eshak E.S., Iso H., Mizoue T., Inoue M., Noda M., Tsugane S. Soft drink, 100% fruit juice, and vegetable juice intakes and risk of diabetes mellitus. Clin Nutr 2013, 32(2):300-308.
10. Clifford M.N. Chlorogenic acids and other cinnamates. Nature, occurrence and dietary burden. J Sci Food Agric 1999, 79:362-372.
11. Petersen M., Simmonds M.S. Rosmarinic acid. Phytochemistry 2003, 62:121-125.
12. Hamaguchi T., Ono K., Murase A., Yamada M. Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway. Am J Pathol 2009, 175:2557-2565.
13. Joy K.L., Kuttan R. Antidiabetic activity of Picrorrhiza kurrora extract. J Ethnopharmacol 1999, 167:143-148.
14. Sasaki T., Matsy S., Sonae A. Effect of acetic acid concentration on the colour reaction in the O-toludiene boric acid method for the blood glucose estimation. Risnh Kagaku 1972, 1:346-353.
15. Natelson S., Scott M.L., Beffa C. A rapid method for the estimation of urea in biologic fluids. Am J Clin Pathol 1951, 21(3):275-281.
16. Caraway W.T. Determination of uric acid in serum by a carbonate method. Am J Clin Pathol 1955, 25(7):840-845.
17. Brod J., Sirota J.H. The renal clearance of endogenous createnine in man. J Clin Invest 1948, 27(5):645-654.
18. Matthews D., Hosker J., Rudenski A., Naylor B., Treacher D., Turner R. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
19. King J. The transaminases: alanine and aspartate transaminases. Practical clinical enzymology 1965, 363-395. Nostrand Co., London. D. Van (Ed.).
20. King J. The hydrolases-acid and alkaline phosphatases. Practical clinical enzymology 1965, 199-208. Nostrand Co., London. D. Van (Ed.).
21. Brandstrup N., Kirk J.E., Bruni C. The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerontol 1957, 12:166-171.
22. Pogson C.I., Denton R.M. Effect of alloxan diabetes, starvation and refeeding on glycolytic kinase activities in rat epididymal adipose tissue. Nature 1967, 216:156-157.
23. King J. A routine method for the estimation of lactic dehydrogenase activity. J Med Lab Technol 1959, 16:265-272.
24. Koide H., Oda T. Pathological occurrence of glucose-6-phosphatase in serum in liver diseases. Clin Chim Acta 1959, 4:554-561.
25. Gancedo J.M., Gancedo C. Fructose-1, 6-diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and non fermenting yeasts. Arch Mikrobiol 1971, 76:132-138.
26. Ells H.A., Kirkman H.N. A colorimetric method for assay of erythrocytic glucose-6-phosphate dehydrogenase. Proc Soc Exp Biol Med 1961, 106:607-609.
27. Leloir L.F., Goldemberg S.H. Glycogen synthetase from rat liver: (Glucose)n+ (UDPG)→(Glucose)n+1+UDP. Methods in enzymology 1962, 145-147. Academic Press, New York. S.P. Colowick, N.O. Kalpan (Eds.).
28. Cornblath M., Randle P.J., Parmeggiani A., Morgan H.E. Regulation of glycogenolysis in muscle. Effects of glucagon and anoxia on lactate production, glycogen content, and phosphorylase activity in the perfused isolated rat heart. J Biol Chem 1963, 238:1592-1597.
29. Morales M.A., Jabbagy A.J., Terenizi H.R. Mutations affecting accumulation of glycogen. Neurospora News 1973, 20:24-25.
30. Shulman G.I. Cellular mechanisms of insulin resistance. J Clin Invest 2000, 106:171-176.
31. Shah B.R., Hux J.E., Laupacis A., Zinman B., van Walraven C. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?. Diabetes Care 2005, 28:600-606.
32. Loew D., Kaszkin M. Approaching the problem of bioequivalence of herbal medicinal products. Phytother Res 2002, 16:705-711.
33. Jaiswal D., Rai P.K., Watal G. Antidiabetic effect of withania coagulans in experimental rats. Indian J Clin Biochem 2009, 24:88-93.
34. Epp R.A., Susser S.E., Morissettee M.P., Kehler D.S., Jassal D.S., Duhamel T.A. Exercise training prevents the development of cardiac dysfunction in the low dose streptozotocin diabetic rats fed a high fat diet. Can J Physiol Pharmacol 2013, 91(1):80-89.
35. Cao S., Li B., Yi X., Chang B., Zhu B., Lian Z., et al. Effects of exercise on AMPK signaling and downstream components to PI3K in rat with type 2 diabetes. PLoS One 2012, 7(12):51709.
36. Subash Babu P., Prabuseenivasan P., Ignacimuthu S. Cinnamaldehyde - a potential antidiabetic agent. Phytomedicine 2007, 14:15-22.
37. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat?. Diabetes 2005, 54:1-7.
38. + handling in rat islets of Langerhans. J Endocrinol 1985, 107(1):1-8.
39. Abdul-Ghani M.A., Tripathy D., DeFronzo R.A. Contributions of beta cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006, 29:1130-1139.
40. 1c in predicting diabetes risk. J Gen Intern Med 2004, 19:1175-1180.
41. Almdal T.P., Vilstrup H. Effects of streptozotocin induced diabetes and diet on nitrogen loss from organs and on the capacity of urea synthesis in rats. Diabetologica 1987, 30(12):952-956.
42. Egbuonu A.C.C., Obidoa O., Ezeokonkwo C.A., Ejikeme P.M., Ezeanyika L.U.S. Some biochemical effects of sub-acute oral administration of L-arginine on monosodium glutamate-fed Wistar albino rats 1: body weight changes, serum cholesterol, creatinine, and sodium ion concentrations. Toxicol Environ Chem 2010, 92:1331-1337.
43. Fortson W.C., Tedesco F.J., Starnes E.C., Shaw C.T. Marked elevation of serum transaminase activity associated with extra hepatic biliary tract disease. J Clin Gastroenterol 1985, 76:502-505.
44. Obrien R.M., Granner D.K. Regulation of gene expression by insulin. Biochem J 1991, 278:9-19.
45. Meyer C., Woerle H.J., Dostou J.M., Welle S.L., Gerich J.E. Abnormal renal, hepatic and muscle glucose metabolism following glucose ingestion in type 2 diabetes. Am J Physiol Endocrinol Metab 2004, 287:1049-1056.
46. Wajngot A., Chandramouli V., Schumann W.C., Ekberg K., Jones P.K., Efendic S., et al. Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus. Metabolism 2001, 50:47-52.
47. Matschinsky F.M. Assessing the potential of glucokinase activators in diabetes therapy. Nat Rev Drug Discov 2009, 8:399-441.
48. Postic C., Shiota M., Magnuson M.A. Cell-specific roles of glucokinase in glucose homeostasis. Recent Prog Horm Res 2001, 56:195-217.
49. Taylor R., Agius L. The biochemistry of diabetes. Biochem J 1988, 250:625-640.
50. Kavanagh K.L., Elling R.A., Wilson D.K. Structure of Toxoplasma gondii LDH1: active-site differences from human lactate dehydrogenases and the structural basis for efficient APAD+ use. Biochemistry 2004, 43:879-889.
51. Kurosaki E., Nakano R., Momose K., Shimaya A., Suzuki T., Shibasaki M., et al. Hypoglycemic agent YM440 suppresses hepatic glucose output via gluconeogenesis by reducing glucose-6-phosphatase activity in obese Zucker rats. Eur J Pharmacol 2003, 468:151-158.
52. Pilkis S.J., Claus T.H. Hepatic gluconeogenesis/glycolysis: regulation and structure/function relationships of substrate cycle enzymes. Annu Rev Nutr 1991, 11:465-515.
53. Massillon D., Barzilai N., Chen W., Hu M., Rossetti L. Glucose regulates in vivoglucose-6-phosphatase gene expression in the liver of diabetic rats. J Biol Chem 1996, 271:9871-9874.
54. Chen R., Meseck M., McEvoy R.C., Woo S.L. Glucose-stimulated and self-limiting insulin production by glucose-6-phosphatase promoter driven insulin expression in hepatoma cells. Gene Ther 2000, 7:1802-1809.
55. Xu Y., Osborne B.W., Stanton R.C. Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am J Physiol 2005, 289:1040-1047.
56. West I.C. Glucose-6-phosphate dehydrogenase: a candidate gene for diabetes. Diabet Med 2002, 19:172-174.
57. Pederson B.A., Schroeder J.M., Parker G., Smith M.W., DePaoli-Roach A.A., Roach P.J. Glucose metabolism in mice lacking muscle glycogen synthase. Diabetes 2005, 54:3466-3473.
58. Parker G., Taylor R., Jones D., McClain D. Hyperglycemia and inhibition of glycogen synthase in streptozotocin-treated mice: role of O-linked N acetylglucosamine. J Biol Chem 2004, 279:20636-20642.